Sign In

Credits Offered

  • Continuing Medical Education (CME): 11.0 AMA PRA Category 1 Credits™
  • Maintenance of Certification (MOC): 11.0 MOC Points

Accreditation and Designation Statements

Continuing Medical Education (CME)
The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AASLD designates this live activity for a maximum of 11.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Maintenance of Certification (MOC)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for granting ABIM MOC credit.

CME Credits

Physicians and other health care professionals seeking AMA PRA Category 1 Credits™ for this live continuing medical education activity must complete an evaluation by Tuesday, April 17, 2018. A link to the CME and MOC evaluation will be emailed to attendees after the conference.

Certificates will only be issued to those who complete an evaluation by the deadline. CME certificates will be emailed upon successful completion of the evaluation.


Physicians seeking ABIM MOC points must complete the CME evaluation and the MOC evaluation by Tuesday, April 17, 2018. Requests for MOC after this date will not be honored. The MOC evaluation is included in the CME evaluation that will be emailed to all attendees, and will remain live until the deadline.

MOC points will be reported to the ABIM by the end of April 2018 for attendees who successfully complete the MOC evaluation.

Course Description/Need Statement

The Emerging Trends Conference - Cholangiopathies: The Dawn of Curative Treatments? conference will review the most recent advances in genetics, pathogenesis and treatment opportunities of cholangiopathies. The conference will assist in facilitating the development of new research collaborations and clinical trials to improve the outcome of children and adults with biliary diseases. Future research directions, including biomarker development and emerging therapeutic possibilities will also be discussed in depth.

Learning Objectives

  • To provide a state of the art review of the most recent advances in pathophysiology of cholangiopathies, with particular emphasis on future treatment opportunities.
  • To define and reconcile current areas of controversy, delineate future avenues of research and highlight translational opportunities (novel therapies).
  • To recognize the most relevant knowledge gaps and to boost collaborative studies to solve them

Target Audience

  • Hepatologists
  • Gastroenterologist
  • Fellows/Trainee
  • Basic Scientists

This activity was planned in the context of the following ACGME/IOM/IPEC competencies: Patient Care, Evidence-based Practice, Medical Knowledge, Practice-Based Learning and Improvement.